Cover Image
市場調查報告書

社區型細菌性肺炎:全球臨床實驗檢討

Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 320828
出版日期 內容資訊 英文 111 Pages
訂單完成後即時交付
價格
Back to Top
社區型細菌性肺炎:全球臨床實驗檢討 Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月30日 內容資訊: 英文 111 Pages
簡介

社區型細菌性肺炎,會作為胸部疼痛,咳嗽,有痰,呼吸困難,寒氣,發冷,發熱,或和低血壓症相關,定義為肺實質的急性細菌感染,胸部X光掃描影像中,伴隨新的肺葉或多葉性浸潤的存在。引起內細菌性肺炎,代表性細菌性病原體,有肺炎球菌、流感菌、Moraxella catarrhalis等。還有肺炎披衣菌、肺炎黴漿菌、嗜肺性退伍軍人桿菌等,典型性的細菌性病原體,也引起社區型細菌性肺炎。

本報告提供社區型細菌性肺炎的治療藥相關臨床實驗調查分析、臨床實驗數及受驗人數、各階段及各方面狀況、有潛力的企業、正在開發的治療藥的資訊、臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東、非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:對感染性疾病臨床實驗的社區型細菌性肺炎的比例

G7各國的臨床實驗:各Phase

G7各國的臨床實驗:各階段

E7各國的臨床實驗:對感染性疾病臨床實驗的社區型細菌性肺炎的比例

E7各國的臨床實驗:各Phase

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

各評估項目臨床實驗

未完成的臨床實驗

一定期間採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 社區型細菌性肺炎的治療藥參與臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Actavis plc
    • Cempra, Inc.
    • Pfizer Inc.
    • Cempra Pharmaceuticals, Inc.
    • AstraZeneca PLC
    • Nabriva Therapeutics AG
    • Cubist Pharmaceuticals, Inc.
    • Boehringer Ingelheim Auslandsbeteiligungs GmbH
    • Bayer AG
    • Basilea Pharmaceutica AG
  • 主要大學、研究機關、醫院臨床實驗概要
    • 橫濱勞災病院
    • Nagasaki Evaluation Organization for Clinical Interventions(NEOCI)
    • 中日本呼吸系統臨床研究機構(CJLSG)
    • Albany Medical Center

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2441CTIDB

GlobalData's clinical trial report, "Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Community-Acquired Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Bacterial Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Community-Acquired Bacterial Pneumonia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Community-Acquired Bacterial Pneumonia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Community-Acquired Bacterial Pneumonia
    • Sep 25, 2014: Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Cempra, Inc.
      • Clinical Trial Overview of Cempra, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Cempra Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cempra Pharmaceuticals, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Nabriva Therapeutics AG
      • Clinical Trial Overview of Nabriva Therapeutics AG
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Boehringer Ingelheim Auslandsbeteiligungs GmbH
      • Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Basilea Pharmaceutica AG
      • Clinical Trial Overview of Basilea Pharmaceutica AG
    • Clinical Trial Overview of Top Institutes / Government
      • Yokohama Rosai Hospital
      • Clinical Trial Overview of Yokohama Rosai Hospital
      • Nagasaki Evaluation Organization for Clinical Interventions
      • Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions
      • Central Japan Lung Study Group
      • Clinical Trial Overview of Central Japan Lung Study Group
      • Albany Medical Center
      • Clinical Trial Overview of Albany Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community-Acquired Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra Pharmaceuticals, Inc., 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nabriva Therapeutics AG, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama Rosai Hospital, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Japan Lung Study Group, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Albany Medical Center, 2014*

List of Figures

  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community-Acquired Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top